Survey Highlights Preference for Human-in-the-Loop AI in Healthcare

According to a recent LinkedIn post from Carta Healthcare, a national survey of U.S. healthcare leaders conducted by Reaction Data suggests that human review is the primary driver of trust in AI among clinicians. The post notes that 67% of respondents pointed to a human reviewing AI output, rather than algorithmic confidence scores or vendor accuracy claims, as the key trust factor.

The post further characterizes a human-in-the-loop “Hybrid Intelligence” approach as the preferred operating model, rather than a compromise between manual and automated processes. For investors, this emphasis on hybrid workflows may indicate ongoing demand for AI tools that are tightly integrated with clinical oversight, potentially supporting adoption of Carta Healthcare’s offerings in hospitals and health systems.

If Carta Healthcare’s products are aligned with this hybrid model, the survey results could strengthen the company’s value proposition with risk-averse healthcare buyers and influence purchasing criteria in enterprise deals. More broadly, the sentiment highlighted in the post underscores that pure automation in clinical AI may face adoption headwinds, which could benefit vendors positioned around augmenting, rather than replacing, human expertise.